We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/1/2018 07:51 | RNS: Not lot of cash but very good news if it broadens scope and market visibility. | small crow | |
15/1/2018 21:42 | Why would they stop when this is worth over 100pIdiots are selling Wrong priceDimw disappeared! | tilly99 | |
15/1/2018 18:57 | A notification has to be made at 3% then every subsequent 1% increment so that would have been a 7% notification. | pyglet | |
15/1/2018 07:25 | Not so tiny small crow. Last BoA notification was when they had 6.14%, they now have over 7%.It is clear that there is steady acquisition of shares by ML and BoA going on. I don't believe they have finished. | longshanks | |
14/1/2018 19:17 | I believe IMM has the higher upside than Motif but both good potential. Some similarities with FDA fast track. IMM have high safety and efficacy profiles, a multi treatment platform v Mtfb a novel antibiotic which is effective against a much needed multi resistant bacteria. Not sure of market revenue potential of Motif but 50000 patents at 20k$ gives a 1 billion product for IMM. Statistically 66% of companies get through p3 and then 90% of those pass FDA submission if I understand FDA site correctly. | velofrance1 | |
13/1/2018 10:57 | New presentation available. | t-trader | |
13/1/2018 09:46 | Just my oppinion as i hold both, a larger amount in imm after the rise though. I think if lupuzor has good results, which is expected then just with lupus they will have a greater market, plus the prospect of ph 3 trials for several other autoimmune diseases, With motif they have already had good results and are due a rerate, the catalist may be the FDA approval, Both could be taken out or sign licencing deals. Im Sure both will be successfull, as always with pharma and shares a waiting game. | barriew | |
12/1/2018 19:32 | Hi all im invested here as well as imm as well , maybe a stupid question dose this have the upside imm has , i see the share is played a lot and is getting held back | scoredagain | |
12/1/2018 15:44 | Tiny increase though - surely that doesn't have to be notified? Correction to original figures perhaps?? | small crow | |
12/1/2018 15:37 | Another holdings increase by BOA. | t-trader | |
11/1/2018 16:24 | Can't believe it's down | pyglet | |
11/1/2018 15:44 | Yes good to see ML showing more confidence by increasing their stake to just under 7%. Got to see this rerate going into licence submission and I expect us to be over 60-70p by submission and significantly higher on grant of Licence. | adorling | |
11/1/2018 15:09 | Merril Lynch increasing their stake | pyglet | |
09/1/2018 12:01 | Ntkn: Neurotoken?Where are you trading that? | longshanks | |
09/1/2018 12:00 | Sorry long shanks Yes WDC!! Ok ok I am forgetful and like WDC and ntknNot sure it makes much difference which is no 3 and which is no 4!! Hhaha | tilly99 | |
09/1/2018 11:48 | Close above 42p is bullish | toolsmoker | |
09/1/2018 11:06 | You change your mind like the wind Tilly. Your other share choice is/was WDC. | longshanks | |
09/1/2018 11:00 | One of my 3 for this year MtfbBluNtkn | tilly99 | |
09/1/2018 10:29 | Needs to break 45p first IMO. | longshanks | |
09/1/2018 10:26 | This will be back at 52p by end of week would imagine loads of wareetns to be exersised so a few mill to motif to come in .all helps expect 85p to 100p by summer here | toolsmoker | |
09/1/2018 10:23 | Really starting to motor now and chart looks great.....about time too. | t-trader | |
09/1/2018 10:22 | Agl isnt doing too well either, whilst the dog of dogs of dogs iofina looks to be making a slight comeback!!!!! | escapetohome | |
09/1/2018 10:15 | MTFB surging whilst that dog IMM keeps sinking lower | longshanks |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions